Bristol Myers Squibb and Bain Capital Unite to Pioneer Breakthroughs in Autoimmune Disease Treatments

Bristol Myers Squibb and Bain Capital have formed NewCo, a biotech company focused on autoimmune disease treatments, starting with five drug candidates and a $300 million investmen...